US Pharm. 2016;41(12):12.

Haarlem, the Netherlands—GlaxoSmithKline (GSK) has been ranked first in the Access to Medicine Index for the fifth consecutive time. The Access to Medicine Index is an independent measure of the top 20 pharmaceutical companies’ efforts to improve access to healthcare in developing countries. It is a major initiative of the Access to Medicine Foundation, an international not-for-profit organization based in the Netherlands. Launched in 2008 and issued every 2 years, the index ranks individual companies based on their performance across seven strategic and technical areas, including research and development, pricing, and product donations. Johnson & Johnson has risen steadily up the list and is now ranked second, followed by Novartis.

To comment on this article, contact